My pick is TH prior to unblinding who were real trial patients...

My pick is TH prior to unblinding who were real trial patients and sham trial patients. The company would want to secure their position once that data is available. TH then access the data, that way any chance of info breaking prior to LCT announcement is ruled out. The data will have to be analyzed , analyzed and analyzed. double i dots and trebble t crosses. The world and especially other large companies with a vested interest in the Parkinsons space will be diligent, as Whytee commented their are some extremely Big Players that will have to change direction if the Phase II results are positive..or get on board with LCT as fast as possible.